review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | T A Wynn | |
P2860 | cites work | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 | Q24310131 | ||
Toll-like receptor signalling | Q24570126 | ||
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis | Q24597767 | ||
High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). | Q24815153 | ||
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
IL-13 effector functions | Q28180348 | ||
Myofibroblasts and mechano-regulation of connective tissue remodelling | Q28216468 | ||
Regulation of immune responses by TGF-beta | Q28271433 | ||
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 | ||
Transforming growth factor-beta regulation of immune responses | Q28303115 | ||
RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis | Q28307643 | ||
Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis | Q28510600 | ||
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response | Q28512142 | ||
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 | Q28591681 | ||
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 | ||
Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation | Q40646262 | ||
BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells | Q40658343 | ||
Biology of the scleroderma fibroblast | Q40835784 | ||
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo | Q40883930 | ||
Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma | Q41005869 | ||
Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. | Q41063030 | ||
Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease | Q41078715 | ||
Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury | Q41182225 | ||
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). | Q42101278 | ||
Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells | Q42448855 | ||
Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts | Q42458917 | ||
Impaired development of Th2 cells in IL-13-deficient mice. | Q42462315 | ||
IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling | Q42518399 | ||
Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity | Q42944220 | ||
IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo | Q43459130 | ||
IL-12 attenuates bleomycin-induced pulmonary fibrosis | Q43638697 | ||
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats | Q43720079 | ||
Protection from pulmonary fibrosis in the absence of CCR2 signaling | Q43760123 | ||
Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. | Q43771291 | ||
Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism | Q43803694 | ||
Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis | Q43997200 | ||
IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent | Q44007756 | ||
Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). | Q44103977 | ||
Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis | Q44160763 | ||
In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis | Q44536872 | ||
Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. | Q44580904 | ||
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. | Q44598571 | ||
Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice | Q44771554 | ||
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent | Q44826352 | ||
Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking | Q44929886 | ||
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. | Q45965385 | ||
Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni | Q37656800 | ||
Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. | Q38309766 | ||
Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction | Q38317997 | ||
Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice | Q38584976 | ||
Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender | Q38882456 | ||
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling | Q39735936 | ||
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation | Q39737420 | ||
Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. | Q39804205 | ||
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors | Q39807542 | ||
Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. | Q40225932 | ||
A role for C-C chemokines in fibrotic lung disease | Q40400981 | ||
Inhibition of airway remodeling in IL-5-deficient mice | Q40553706 | ||
Mesenchymal stem cells as trophic mediators | Q29619806 | ||
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis | Q29620566 | ||
The role of CXC chemokines in pulmonary fibrosis | Q30443091 | ||
Macular degeneration: recent advances and therapeutic opportunities. | Q33260025 | ||
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair | Q33565774 | ||
Airway remodeling in asthma | Q33753444 | ||
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection | Q33852941 | ||
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response | Q33853821 | ||
Epithelial origin of myofibroblasts during fibrosis in the lung | Q33996286 | ||
Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo | Q34187677 | ||
Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression | Q34371002 | ||
Angiotensin II and renal fibrosis. | Q34376512 | ||
Matrix as a modulator of hepatic fibrogenesis | Q34391368 | ||
CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury | Q34399563 | ||
Non-Smad TGF-beta signals | Q34443708 | ||
Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. | Q34491845 | ||
Transforming growth factor-beta in T-cell biology | Q34572232 | ||
The enemy within: keeping self-reactive T cells at bay in the periphery | Q34573771 | ||
The IL-21 receptor augments Th2 effector function and alternative macrophage activation | Q34682153 | ||
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice | Q35141654 | ||
Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta | Q35157728 | ||
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon | Q35594665 | ||
Viral hepatitis C. | Q35617324 | ||
Mechanisms of pulmonary fibrosis | Q35640281 | ||
Systemic sclerosis: a prototypic multisystem fibrotic disorder | Q35649427 | ||
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ | Q35649446 | ||
Infectious disease, the innate immune response, and fibrosis | Q35649461 | ||
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 | ||
Fibrosis and diseases of the eye. | Q35649477 | ||
Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13 | Q35669762 | ||
Mechanisms of tubulointerstitial fibrosis | Q35741776 | ||
Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. | Q35747373 | ||
Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation | Q35788867 | ||
Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice | Q35792147 | ||
NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease | Q35829420 | ||
TGF-beta1 and angiotensin networking in cardiac remodeling | Q35846911 | ||
Fibrotic disease and the T(H)1/T(H)2 paradigm | Q35852270 | ||
Morbidity in schistosomiasis: an update | Q35881149 | ||
IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice | Q35995705 | ||
Angiotensin II and the endothelium: diverse signals and effects | Q35998553 | ||
The eosinophil enigma | Q36057112 | ||
Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. | Q36123039 | ||
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome | Q36168370 | ||
Chemokines provide the sustained inflammatory bridge between innate and acquired immunity | Q36168977 | ||
Angiotensin and diabetic retinopathy | Q36258479 | ||
Scleroderma: from cell and molecular mechanisms to disease models | Q36259889 | ||
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications | Q36304061 | ||
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma | Q36369722 | ||
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. | Q36370592 | ||
Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response | Q36370595 | ||
Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis | Q36371784 | ||
Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction | Q36403987 | ||
The role of circulating fibrocytes in fibrosis | Q36434149 | ||
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair | Q36437461 | ||
Matrix metalloproteases in aberrant fibrotic tissue remodeling | Q36493982 | ||
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis | Q36524368 | ||
Reversal of fibrosis: no longer a pipe dream? | Q36680444 | ||
ECM remodeling in hypertensive heart disease | Q36749281 | ||
Molecular mechanisms of hepatic fibrogenesis | Q36849062 | ||
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. | Q36884168 | ||
Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction | Q36991087 | ||
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis | Q37117400 | ||
CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation | Q37303070 | ||
Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung | Q37370914 | ||
Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice | Q37375446 | ||
Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity | Q37443188 | ||
Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis | Q37591872 | ||
IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome | Q46046480 | ||
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung | Q46903300 | ||
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis | Q47839389 | ||
The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. | Q48032045 | ||
Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. | Q48662058 | ||
The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling. | Q50232342 | ||
The role of IL-13 in established allergic airway disease. | Q51696824 | ||
The bone marrow functionally contributes to liver fibrosis. | Q51805517 | ||
Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. | Q52543547 | ||
Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4Ralpha-independent airway hyperreactivity. | Q52957179 | ||
Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet. | Q53569849 | ||
TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. | Q54276983 | ||
IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease | Q57339957 | ||
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection | Q59054213 | ||
Bone marrow endothelial progenitors are defective in systemic sclerosis | Q62395162 | ||
The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts | Q64379370 | ||
Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents | Q67881646 | ||
Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury | Q71656900 | ||
A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) | Q72034277 | ||
Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis | Q72037712 | ||
A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice | Q72989109 | ||
Bleomycin-induced pulmonary fibrosis is independent of eosinophils | Q73092965 | ||
Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis | Q73258653 | ||
Interferon-gamma inhibits experimental renal fibrosis | Q73265447 | ||
Interleukin-10- and corticosteroid-induced reduction in type I procollagen in a human ex vivo scar culture | Q73372275 | ||
Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice | Q73458501 | ||
Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts | Q73478890 | ||
Intestinal myofibroblasts in innate immune responses of the intestine | Q73524252 | ||
Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy | Q73606421 | ||
Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma | Q73720946 | ||
IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis | Q73869153 | ||
Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease | Q74027234 | ||
Proteome analysis of rat hepatic stellate cells | Q74071343 | ||
IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation | Q74080040 | ||
Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody | Q74089397 | ||
IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung | Q74244301 | ||
Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma | Q74417771 | ||
Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases | Q77337921 | ||
The role of IL-5 in bleomycin-induced pulmonary fibrosis | Q77584421 | ||
Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis | Q77598613 | ||
Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice | Q77598616 | ||
Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair | Q79074374 | ||
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts | Q79795007 | ||
Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma | Q80427980 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 199-210 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | Cellular and molecular mechanisms of fibrosis | |
P478 | volume | 214 |
Q33784875 | "Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression". |
Q42594342 | "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology. |
Q48100691 | 11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis. |
Q92996418 | 15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism |
Q36597906 | 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice |
Q90393375 | 2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages |
Q92875864 | 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma |
Q35558533 | 5Z-7-Oxozeanol Inhibits the Effects of TGFβ1 on Human Gingival Fibroblasts |
Q88418993 | A High-Throughput Assay for Collagen Secretion Suggests an Unanticipated Role for Hsp90 in Collagen Production |
Q41789743 | A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin |
Q27333100 | A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis |
Q36987505 | A Novel Nude Mouse Model of Hypertrophic Scarring Using Scratched Full Thickness Human Skin Grafts |
Q36074303 | A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity. |
Q37402787 | A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity |
Q36421134 | A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo |
Q41294425 | A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-β1 and Suppresses Ongoing Hepatic Fibrosis |
Q46276542 | A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix |
Q36468611 | A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy |
Q40642188 | A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development |
Q49964268 | A comparative study of different amniotic membrane orientations during extraocular muscle surgery in rabbits. |
Q60932297 | A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients |
Q91895471 | A dose-ranging, parallel group, split-face, single-blind phase II study of light emitting diode-red light (LED-RL) for skin scarring prevention: study protocol for a randomized controlled trial |
Q41642597 | A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection |
Q35185363 | A key role for NOX4 in epithelial cell death during development of lung fibrosis. |
Q42795715 | A large shRNA library approach identifies lncRNA Ntep as an essential regulator of cell proliferation |
Q30155283 | A lipocalin-derived Peptide modulating fibroblasts and extracellular matrix proteins |
Q33761119 | A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses |
Q38393165 | A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis |
Q39697103 | A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy |
Q47291343 | A novel personalized 3D injectable protein scaffold for regenerative medicine |
Q34116805 | A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model |
Q55026656 | A phosphatidylinositol 3-kinase inhibitor strongly suppressed pulmonary vascular remodeling of allergic vasculitis in a murine model. |
Q38929057 | A potent peptide as adiponectin receptor 1 agonist to against fibrosis |
Q82770866 | A randomized prospective study of rehabilitation therapy in the treatment of radiation-induced dysphagia and trismus |
Q37404262 | A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis |
Q36905046 | A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response |
Q34870775 | A2B adenosine receptor-mediated induction of IL-6 promotes CKD. |
Q35138448 | ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. |
Q36375659 | ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers |
Q50873709 | AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis. |
Q38698086 | AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation. |
Q41822988 | Aberrant repair and fibrosis development in skeletal muscle |
Q41520500 | Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice |
Q39999843 | Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts |
Q33396838 | Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2. |
Q38448103 | Accumulation of isolevuglandin-modified protein in normal and fibrotic lung |
Q36488760 | Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation |
Q42283646 | Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis |
Q39010818 | Activated human hepatic stellate cells promote growth of human hepatocellular carcinoma in a subcutaneous xenograft nude mouse model |
Q35767861 | Activated rat hepatic stellate cells influence Th1/Th2 profile in vitro |
Q37240461 | Activation of MRTF-A-dependent gene expression with a small molecule promotes myofibroblast differentiation and wound healing |
Q42638573 | Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis |
Q35863725 | Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis |
Q37649641 | Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases |
Q51859653 | Activation of the renin-angiotensin system in hyperoxia-induced lung fibrosis in neonatal rats. |
Q64052496 | Activin a promotes myofibroblast differentiation of endometrial mesenchymal stem cells via STAT3-dependent Smad/CTGF pathway |
Q36478984 | Adamts1 mediates ethanol-induced alterations in collagen and elastin via a FoxO1-sestrin3-AMPK signaling cascade in myocytes |
Q33765783 | Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism. |
Q36385392 | Adenosine A2A receptor plays an important role in radiation-induced dermal injury |
Q50197688 | Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis. |
Q98158698 | Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion |
Q37202779 | Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis |
Q36306603 | Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway |
Q53187823 | Adipose tissue-derived stem cell treatment prevents renal disease progression. |
Q37813497 | Adipose-derived stem cells for myocardial infarction |
Q89976304 | Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats |
Q96953397 | Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity |
Q42719423 | Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis |
Q36929585 | Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. |
Q26799872 | Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing |
Q99551284 | Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells |
Q46280910 | Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension |
Q35235846 | Adverse host factors exacerbate occult HIV-associated nephropathy |
Q38932043 | Adverse outcome pathway development from protein alkylation to liver fibrosis |
Q42307037 | Adverse outcome pathways: opportunities, limitations and open questions |
Q36063298 | Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation |
Q57100000 | Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma |
Q45977362 | Age-related external anal sphincter muscle dysfunction and fibrosis: possible role of Wnt/β-catenin signaling pathways. |
Q35155965 | Aging and Cardiac Fibrosis. |
Q87851625 | Allograft inflammatory factor-1 alleviates liver disease of BALB/c mice infected with Schistosoma japonicum |
Q45807860 | Allopurinol reverses liver damage induced by chronic carbon tetrachloride treatment by decreasing oxidative stress, TGF-β production and NF-κB nuclear translocation |
Q42665165 | Alphav integrins lead the way for colorectal metastases |
Q33686113 | Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium |
Q37972397 | Alternative origins of stroma in normal organs and disease |
Q51193055 | Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin. |
Q47235420 | Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair |
Q34964361 | Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage |
Q42396082 | Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis |
Q35009520 | Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists |
Q33882346 | An alternative to lung inflammation and fibrosis |
Q37294934 | Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells. |
Q102152233 | Anatomical and histological analyses reveal that tail repair is coupled with regrowth in wild-caught, juvenile American alligators (Alligator mississippiensis) |
Q39629598 | Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis |
Q40428093 | Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. |
Q37490648 | Angiopoietin-like protein 2 induced by mechanical stress accelerates degeneration and hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis |
Q43015011 | Angiotensin II increases mRNA levels of all TGF-beta isoforms in quiescent and activated rat hepatic stellate cells. |
Q30501039 | Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model |
Q28567529 | Angiotensin II promotes development of the renal microcirculation through AT1 receptors |
Q34769458 | Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease |
Q37626862 | Angiotensin Type-2 (AT-2)-Receptor activation reduces renal fibrosis in cyclosporine nephropathy: Evidence for blood-pressure independent effect |
Q31053453 | Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression |
Q33830299 | Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells |
Q34086852 | Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury |
Q37122480 | Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis |
Q38033380 | Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease |
Q40096184 | Another dimension to the importance of the extracellular matrix in fibrosis. |
Q37706081 | Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes. |
Q39427043 | Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice |
Q59803350 | Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers |
Q39453169 | Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease |
Q38850557 | Anti-fibrotic actions of relaxin. |
Q35808540 | Anti-fibrotic effect of natural toxin bee venom on animal model of unilateral ureteral obstruction |
Q38727002 | Anti-fibrotic effects of Salvia miltiorrhiza and Ligustrazine Injection on LX-2 cells involved with increased N-myc downstream-regulated gene 2 expression |
Q41642089 | Anti-fibrotic effects of the Masson pine pollen aqueous extract on hepatic fibrosis rat model. |
Q38895546 | Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms |
Q36837922 | Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis. |
Q44132897 | Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn's disease |
Q33943907 | Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans |
Q39238770 | Antifibrotics in chronic liver disease: tractable targets and translational challenges |
Q39182906 | Antiproliferative and cytotoxic effects of purple pitanga (Eugenia uniflora L.) extract on activated hepatic stellate cells. |
Q24611248 | Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways |
Q54978248 | Aortic carboxypeptidase-like protein enhances adipose tissue stromal progenitor differentiation into myofibroblasts and is upregulated in fibrotic white adipose tissue. |
Q37150761 | Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis. |
Q36667057 | Apobec-1 Complementation Factor (A1CF) Inhibits Epithelial-Mesenchymal Transition and Migration of Normal Rat Kidney Proximal Tubular Epithelial Cells |
Q90290725 | Apoptosis Resistance in Fibroblasts Precedes Progressive Scarring in Pulmonary Fibrosis and Is Partially Mediated by Toll-Like Receptor 4 Activation |
Q53069927 | Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy. |
Q64094470 | Application of Manual Therapy for Dysphagia in Head and Neck Cancer Patients: A Preliminary National Survey of Treatment Trends and Adverse Events |
Q37848921 | Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue |
Q39386624 | Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis |
Q50128617 | Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis. |
Q28387702 | Asbestos-associated mesothelial cell autoantibodies promote collagen deposition in vitro |
Q37317161 | Asiatic acid isolated from Centella asiatica inhibits TGF-β1-induced collagen expression in human keloid fibroblasts via PPAR-γ activation |
Q38873704 | Asiaticoside hinders the invasive growth of keloid fibroblasts through inhibition of the GDF-9/MAPK/Smad pathway |
Q30444857 | Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI |
Q53382047 | Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. |
Q33637776 | Association between depressive symptoms and fibrosis markers: the Cardiovascular Health Study |
Q28070358 | Astaxanthin as a Potential Protector of Liver Function: A Review |
Q34112121 | Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components. |
Q55000649 | Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway. |
Q57268472 | Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients |
Q38023852 | Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. |
Q39319936 | Autophagy and mesenchymal cell fibrogenesis |
Q35274466 | Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts |
Q36227227 | Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. |
Q42875432 | Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model |
Q24658641 | B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease |
Q36105254 | BARD1 mediates TGF-β signaling in pulmonary fibrosis. |
Q47432301 | BDNF-ERK1/2 signaling pathway in ketamine-associated lower urinary tract symptoms |
Q57046535 | BML-111 suppresses TGF-β1-induced lung fibroblast activation in vitro and decreases experimental pulmonary fibrosis in vivo |
Q50583140 | BMP-2 induces a profibrotic phenotype in adult renal progenitor cells through Nox4 activation. |
Q42709318 | BMP-6 emerges as a potential major regulator of fibrosis in the kidney |
Q43613927 | BMP-7 attenuates TGF-β1-induced fibroblast-like differentiation of rat dermal papilla cells |
Q90651745 | BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarring |
Q36419888 | BRD4 is a novel therapeutic target for liver fibrosis |
Q37696175 | Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway. |
Q28383273 | Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes |
Q54250942 | Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway. |
Q38967954 | Basic Signaling in Cardiac Fibroblasts |
Q53159771 | Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development. |
Q45170033 | Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. |
Q93364846 | Biomarkers Associated with Lymphedema and Fibrosis in Patients with Cancer of the Head and Neck |
Q35208530 | Biomaterials that regulate growth factor activity via bioinspired interactions |
Q38237390 | Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer |
Q33730117 | Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent |
Q47776900 | Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors |
Q34263666 | Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis. |
Q34358339 | Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair |
Q41643283 | Blocking HMGB1 signal pathway protects early radiation-induced lung injury. |
Q35064880 | Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice |
Q91690142 | Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation |
Q33360714 | Blocking of angiotensin II is more than blocking of transforming growth factor-beta |
Q33943997 | Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy |
Q29048610 | Blocking the 4-1BB Pathway Ameliorates Crystalline Silica-induced Lung Inflammation and Fibrosis in Mice |
Q34559028 | Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling |
Q39402781 | Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. |
Q37617540 | Bone regeneration: the stem/progenitor cells point of view |
Q50087003 | Brg1 promotes liver fibrosis via activation of hepatic stellate cells. |
Q90492059 | CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart |
Q38861910 | CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia |
Q35740902 | CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion |
Q92377646 | CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis |
Q55024109 | CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. |
Q34027926 | CCN1/CYR61: the very model of a modern matricellular protein. |
Q53404791 | CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β. |
Q36703006 | CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation |
Q52844028 | CD31+ Cells From Peripheral Blood Facilitate Bone Regeneration in Biologically Impaired Conditions Through Combined Effects on Immunomodulation and Angiogenesis. |
Q34490750 | CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis |
Q37394389 | CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes |
Q84618859 | CD4+ T cells: a potential player in renal fibrosis |
Q45715929 | CD44v3-v10 reduces the profibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy |
Q39493006 | CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy |
Q43159403 | CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis |
Q34485215 | CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis |
Q50309115 | CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled To Cullin-RING Ubiquitin Ligase Activation. |
Q58779664 | CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis |
Q35790264 | Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition |
Q41840520 | Caffeic Acid Phenethyl Ester inhibit Hepatic Fibrosis by Nitric Oxide Synthase and Cystathionine Gamma-Lyase in Rats |
Q92752898 | Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease? |
Q42334109 | Can a fibrotic liver afford epithelial-mesenchymal transition? |
Q57170745 | Can host reaction animal models be used to predict and modulate skin regeneration? |
Q86151439 | Canine visceral leishmaniasis as a systemic fibrotic disease |
Q42178812 | Cardiac Lymphatic Vessels, Transport, and Healing of the Infarcted Heart. |
Q35174316 | Cardiac MR imaging to probe tissue composition of the heart by using T1 mapping |
Q38103213 | Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers. |
Q34162142 | Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. |
Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
Q51695893 | Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis. |
Q52659952 | Cartilage oligomeric matrix protein: COMPopathies and beyond. |
Q46816517 | Caspase-3 activation and increased procollagen type I in irradiated hearts. |
Q41347086 | Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway |
Q34256372 | Cathepsin S deficiency results in abnormal accumulation of autophagosomes in macrophages and enhances Ang II-induced cardiac inflammation |
Q41382922 | Cell plasticity in wound healing: paracrine factors of M1/ M2 polarized macrophages influence the phenotypical state of dermal fibroblasts |
Q36220879 | Cell signals influencing hepatic fibrosis |
Q38259227 | Cellular and Molecular Mediators of Intestinal Fibrosis |
Q42252132 | Cellular and molecular mechanisms of intestinal fibrosis |
Q35903772 | Cellular and molecular mechanisms of renal fibrosis |
Q96126917 | Cellular census of human fibrosis defines functionally distinct stromal cell types and states |
Q37093579 | Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis |
Q33840143 | Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. |
Q50484272 | Cellular or Exosomal microRNAs Associated with CCN Gene Expression in Liver Fibrosis. |
Q24602488 | Cellular senescence controls fibrosis in wound healing |
Q37848468 | Cellular/extracellular matrix cross-talk in scar evolution and control. |
Q92048945 | Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24 |
Q47839477 | Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum. |
Q49570420 | Characterization of pulmonary responses in mice to asbestos/asbestiform fibers using gene expression profiles. |
Q37434655 | Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. |
Q58758969 | Chemokine-Induced Macrophage Polarization in Inflammatory Conditions |
Q37502208 | Chemokines and cardiac fibrosis. |
Q26778684 | Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring |
Q34056271 | Chemokines in the immunopathogenesis of hepatitis C infection |
Q28484977 | Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children |
Q84797678 | Chronic alcohol consumption induces cardiac remodeling in mice from Th1 or Th2 background |
Q38027046 | Chronic inflammation and lung fibrosis: pleotropic syndromes but limited distinct phenotypes |
Q34448187 | Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts |
Q35102810 | Cinnabar induces renal inflammation and fibrogenesis in rats |
Q49344588 | Circuit Design Features of a Stable Two-Cell System. |
Q64244673 | Circular RNAs in immune responses and immune diseases |
Q34785428 | Circulating microRNAs as a Fingerprint for Liver Cirrhosis |
Q35675409 | Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice |
Q37477801 | Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases. |
Q30583901 | Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features |
Q91741461 | Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis |
Q51428417 | Clinical strategies for the alleviation of contractures from a predictive mathematical model of dermal repair. |
Q86867451 | Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar |
Q38950679 | Coculture with intraocular lens material-activated macrophages induces an inflammatory phenotype in lens epithelial cells |
Q89551749 | ColXV Aggravates Adipocyte Apoptosis by Facilitating Abnormal Extracellular Matrix Remodeling in Mice |
Q64091690 | Collagen Fibrils Mechanically Contribute to Tissue Contraction in an In Vitro Wound Healing Scenario |
Q33840471 | Collagen I matrix turnover is regulated by fibronectin polymerization |
Q34959537 | Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients. |
Q52366287 | Comparative regenerative mechanisms across different mammalian tissues. |
Q36630982 | Comparison of acute proton, photon, and low-dose priming effects on genes associated with extracellular matrix and adhesion molecules in the lungs |
Q40374177 | Comparison of collagen content in skin wounds evaluated by biochemical assay and by computer-aided histomorphometric analysis |
Q41632625 | Comprehensive phenotyping of regulatory T cells after liver transplantation. |
Q37777427 | Congenital ureteropelvic junction obstruction: human disease and animal models |
Q44783314 | Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis |
Q36903759 | Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro. |
Q33637142 | Connexins, Pannexins, and Their Channels in Fibroproliferative Diseases |
Q53763050 | Contractile function recovery in severely injured gastrocnemius muscle of rats treated with either oleic or linoleic acid. |
Q36353622 | Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis. |
Q58799997 | Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment |
Q38879377 | Contribution of collagen adhesion receptors to tissue fibrosis |
Q34905520 | Contribution of intestinal smooth muscle to Crohn's disease fibrogenesis |
Q38046545 | Contribution of myeloid cell subsets to liver fibrosis in parasite infection |
Q36007887 | Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency |
Q53180514 | Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. |
Q64068193 | Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts |
Q36420270 | Cross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosis |
Q38204265 | Crosstalk between fibroblasts and inflammatory cells |
Q47415780 | Cryopreserved rabbit amniotic membrane alleviated inflammatory response and fibrosis following experimental strabismus surgery in rabbits |
Q46682082 | Curative diet supplementation with a melon superoxide dismutase reduces adipose tissue in obese hamsters by improving insulin sensitivity |
Q37624991 | Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition |
Q46654417 | Curcumin prevents cisplatin-induced decrease in the tight and adherens junctions: relation to oxidative stress |
Q37603804 | Current concepts in clinical radiation oncology |
Q49507866 | Current perspectives on the role of CD8+ T cells in systemic sclerosis. |
Q35228505 | Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD |
Q39481263 | Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis. |
Q37899786 | Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family |
Q37209512 | Cytokine mediated tissue fibrosis |
Q50082480 | Cytokines in tendon disease: A Systematic Review. |
Q38543692 | Cytokines in the immunopathology of systemic sclerosis |
Q53105395 | Cytologic features of hepatic fibrosis in dogs: a retrospective study on 22 cases. |
Q35886245 | Cytosolic phospholipase A₂: physiological function and role in disease |
Q93210153 | DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome |
Q33722844 | Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. |
Q54231908 | Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice. |
Q92750611 | Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice |
Q28607792 | Dating Endometriotic Ovarian Cysts Based on the Content of Cyst Fluid and its Potential Clinical Implications |
Q36158847 | Deciphering mechanisms of staphylococcal biofilm evasion of host immunity |
Q57716457 | Deciphering the disease-related molecular networks using urine proteomics |
Q37044614 | Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression |
Q35085132 | Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity |
Q92354819 | Deficient Skeletal Muscle Regeneration after Injury Induced by a Clostridium perfringens Strain Associated with Gas Gangrene |
Q34217585 | Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly |
Q35188138 | Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy |
Q42156139 | Deletion of a tumor necrosis superfamily gene in mice leads to impaired healing that mimics chronic wounds in humans. |
Q37057161 | Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression |
Q42095796 | Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation |
Q53206104 | Depletion of Hepatic Macrophages Aggravates Liver Lesions Induced in Rats by Thioacetamide (TAA). |
Q39402319 | Design, synthesis and anti-fibrosis activity study of N₁-substituted phenylhydroquinolinone derivatives. |
Q45392095 | Detection of Epstein-Barr virus-encoded small RNA-expressed myofibroblasts and IgG4-producing plasma cells in sclerosing angiomatoid nodular transformation of the spleen |
Q44206690 | Development of Fibrosis in Acute and Longstanding Ulcerative Colitis |
Q98196787 | Development of a miniaturized 96-Transwell air-liquid interface human small airway epithelial model |
Q51502123 | Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition. |
Q36296876 | Diabetes-induced renal injury in rats is attenuated by suramin |
Q36589609 | Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis |
Q33820556 | Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice |
Q36414956 | Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis |
Q38568865 | Differential effects of Smad3 targeting in a murine model of chronic kidney disease |
Q48300010 | Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy |
Q40173528 | Differential expression of microRNA and predicted targets in pulmonary sarcoidosis |
Q47135902 | Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice |
Q64264709 | Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice |
Q28387716 | Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences |
Q36040154 | Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis |
Q86531984 | Disease modification in systemic sclerosis. Do integrated approaches offer new challenges? |
Q48341303 | Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation |
Q37129967 | Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta |
Q43791563 | Distinct spatio-temporal extracellular matrix accumulation within demyelinated spinal cord lesions in Theiler's murine encephalomyelitis |
Q26825368 | Diverse functions of matrix metalloproteinases during fibrosis |
Q35581445 | Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses |
Q36923555 | Diversity of lipid mediators in human adipose tissue depots. |
Q41551456 | Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion |
Q47119118 | Drugs and Targets in Fibrosis |
Q91846149 | Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice |
Q41894002 | Dual targeting of MEK and PI3K pathways attenuates established and progressive pulmonary fibrosis. |
Q26775091 | Dynamic role of myofibroblasts in oral lesions |
Q29619873 | Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis |
Q49428049 | Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype. |
Q92494590 | ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis |
Q39879394 | ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. |
Q91933381 | ERK1/2 drives IL-1β-induced expression of TGF-β1 and BMP-2 in torn tendons |
Q38930830 | EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling |
Q60641610 | Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels |
Q37216048 | Early infiltration of p40IL12(+)CCR7(+)CD11b(+) cells is critical for fibrosis development |
Q50070886 | Early intervention by Captopril does not improve wound healing of partial thickness burn wounds in a rat model. |
Q36655405 | Early loss of pericytes and perivascular stromal cell-induced scar formation after stroke |
Q34231374 | Effect of RhoA on transforming growth factor β1-induced rat hepatic stellate cell migration |
Q43021349 | Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis |
Q46590750 | Effect of cryopreserved amniotic membrane on the development of adhesions and fibrosis after extraocular muscle surgery in rabbits |
Q34526130 | Effect of interleukin 6 deficiency on renal interstitial fibrosis |
Q54365521 | Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice. |
Q49580788 | Effect of photobiomodulation on connective tissue remodeling and regeneration of skeletal muscle in elderly rats. |
Q89606643 | Effect of sarcolipin-mediated cell transdifferentiation in sarcopenia-associated skeletal muscle fibrosis |
Q37227633 | Effectiveness of rosiglitazone in reducing flexion contracture in a rabbit model of arthrofibrosis with surgical capsular release: A biomechanical, histological, and genetic analysis |
Q27027082 | Effector mechanisms of rejection |
Q92526479 | Effects of PARP-1 Deficiency and Histamine H4 Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice |
Q33686400 | Effects of nanoporous alumina on inflammatory cell response |
Q54394597 | Effects of silencing transforming growth factor-β1 by RNA interference plasmid on rat renal allograft fibrosis using Smads pathway. |
Q44119643 | Effects of vitamin C on cytotherapy-mediated muscle regeneration |
Q34533385 | Effects on contralateral muscles after unilateral electrical muscle stimulation and exercise |
Q28482283 | Efficacy of a novel class of RNA interference therapeutic agents |
Q37754720 | Eicosanoids in inflammation and cancer: the role of COX-2. |
Q38779316 | Electrostatic and Hydrophobic Interactions Mediate Single-Stranded DNA Recognition and Acta2 Repression by Purine-Rich Element-Binding Protein B. |
Q54237984 | Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis. |
Q34784648 | Elevated serum beta-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats. |
Q36063833 | Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases |
Q92106745 | Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity |
Q38603674 | Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice |
Q38990632 | Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice |
Q54122943 | Endostatin Stimulates Proliferation and Migration of Myofibroblasts Isolated from Myocardial Infarction Model Rats. |
Q47118793 | Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study. |
Q54982965 | Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction. |
Q37278453 | Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. |
Q36173804 | Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype |
Q38555492 | Endothelial-to-mesenchymal transition contributes to the myofibroblast population in proliferative diabetic retinopathy |
Q90522780 | Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy |
Q35141755 | Endotoxin induces fibrosis in vascular endothelial cells through a mechanism dependent on transient receptor protein melastatin 7 activity. |
Q38754809 | Engineering approaches to study fibrosis in 3-D in vitro systems. |
Q37026406 | Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ |
Q37052016 | Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression |
Q26829416 | Environmental attributes to respiratory diseases of small ruminants |
Q28543011 | Environmental particulate (PM2.5) augments stiffness-induced alveolar epithelial cell mechanoactivation of transforming growth factor beta |
Q91720874 | Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space |
Q43257498 | Eosinophils infiltrate thyroids, but have no apparent role in induction or resolution of experimental autoimmune thyroiditis in interferon-gamma(-/-) mice |
Q34735424 | Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells. |
Q38858284 | Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis. |
Q38985933 | Epigenetic regulation of hepatic stellate cell activation and liver fibrosis |
Q36113039 | Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis |
Q38218535 | Epigenetics in radiation-induced fibrosis |
Q38034837 | Epigenetics within the matrix: a neo-regulator of fibrotic disease |
Q90246026 | Epithelial Cell Cycle Behaviour in the Injured Kidney |
Q37591248 | Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury |
Q37762478 | Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer |
Q35107649 | Epithelial regulation of mesenchymal tissue behavior |
Q39242491 | Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis |
Q33947224 | Epithelial to mesenchymal transition in gingival overgrowth |
Q59800302 | Epithelial-mesenchymal transition in keloid tissue |
Q53482048 | Epithelial-mesenchymal transition in keloid tissues and TGF-β1-induced hair follicle outer root sheath keratinocytes. |
Q36104434 | Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis |
Q37456459 | Epithelial-to-mesenchymal transitions in the liver |
Q30656354 | Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition |
Q57821348 | Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis |
Q53759519 | Evaluation of Antivascular Combretastatin A4 P Efficacy Using Supersonic Shear Imaging Technique of Ectopic Colon Carcinoma CT26. |
Q37648477 | Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation |
Q34575461 | Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess model |
Q55155378 | Evaluation of liver fibrosis with a monoexponential model of intravoxel incoherent motion magnetic resonance imaging. |
Q49207421 | Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation. |
Q64901830 | Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS. |
Q93335290 | Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3 |
Q90416829 | Evaluation of transforming growth factor beta 1 in dogs with osteoarthritis |
Q90218556 | Evaluation via Supervised Machine Learning of the Broiler Pectoralis Major and Liver Transcriptome in Association With the Muscle Myopathy Wooden Breast |
Q35903075 | Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis |
Q47763199 | Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway |
Q38006732 | Evolving role of molecular imaging for new understanding: targeting myofibroblasts to predict remodeling |
Q91649266 | Evolving therapies for Peyronie's disease: how can we work towards new drugs? |
Q64235554 | Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts |
Q35204841 | Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats |
Q49918232 | Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis. |
Q94595628 | Expression of Collagen (Types I, III, and V), HSP47, MMP-2, and TIMP-1 in Retrobulbar Adipose Tissue of Patients with Thyroid-Associated Orbitopathy |
Q54548435 | Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes. |
Q42619210 | Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes. |
Q41846598 | Expression of nestin, vimentin, and NCAM by renal interstitial cells after ischemic tubular injury |
Q28472170 | Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications |
Q50513904 | Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. |
Q58725635 | Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment |
Q92092671 | Extracellular matrix composition of connective tissues: a systematic review and meta-analysis |
Q33694487 | Extracellular matrix molecules: potential targets in pharmacotherapy. |
Q36672445 | Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure |
Q37776560 | Extracellular matrix roles during cardiac repair. |
Q91869856 | FGF-2 inhibits contractile properties of valvular interstitial cell myofibroblasts encapsulated in 3D MMP-degradable hydrogels |
Q45869235 | FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice |
Q42577317 | Fabrication of biocompatible, vibrational magnetoelastic materials for controlling cellular adhesion |
Q49721777 | Falcarindiol inhibits LPS-induced inflammation via attenuating MAPK and JAK-STAT signaling pathways in murine macrophage RAW 264.7 cells. |
Q98226258 | Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation |
Q24627446 | Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression |
Q89822068 | FibroAtlas: A Database for the Exploration of Fibrotic Diseases and Their Genes |
Q64296038 | Fibroadhesive scarring of grafted collagen scaffolds interferes with implant-host neural tissue integration and bridging in experimental spinal cord injury |
Q38047232 | Fibroblast autophagy in fibrotic disorders |
Q41090863 | Fibroblast paracrine TNF-α signaling elevates integrin A5 expression in idiopathic pulmonary fibrosis (IPF). |
Q83190809 | Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis |
Q41151245 | Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis |
Q38737904 | Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis |
Q47094281 | Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis |
Q33916995 | Fibroblast-specific expression of AC6 enhances beta-adrenergic and prostacyclin signaling and blunts bleomycin-induced pulmonary fibrosis. |
Q39589852 | Fibroblast/fibrocyte: surface interaction dictates tissue reactions to micropillar implants |
Q37836316 | Fibroblasts and myofibroblasts: what are we talking about? |
Q28390280 | Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease |
Q89831197 | Fibrocytes, Wound Healing, and Corneal Fibrosis |
Q30432829 | Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis |
Q38542592 | Fibrogenesis, novel lessons from animal models |
Q36515027 | Fibronectin regulates Wnt7a signaling and satellite cell expansion |
Q37983629 | Fibroproliferative disorders and their mechanobiology |
Q64954227 | Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia. |
Q35584016 | Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 - a case control study |
Q26801150 | Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family |
Q91511304 | Fibrosis and secondary lymphedema: chicken or egg? |
Q47376188 | Fibrosis imaging: Current concepts and future directions |
Q40556586 | Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury |
Q35825861 | Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages |
Q42908292 | Fibrosis under arrest |
Q33865082 | Fibrosis-dependent mechanisms of hepatocarcinogenesis |
Q34076151 | Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study |
Q37834449 | Fibrotic response of tissue remodeling in COPD. |
Q38947654 | Flightless I is a key regulator of the fibroproliferative process in hypertrophic scarring and a target for a novel antiscarring therapy |
Q47942170 | Fluorescence of Picrosirius Red Multiplexed With Immunohistochemistry for the Quantitative Assessment of Collagen in Tissue Sections. |
Q54571621 | Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation. |
Q53066784 | Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin α, TGF-β and α-SMA. |
Q35688439 | Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. |
Q33518024 | Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art. |
Q36310562 | Follistatin attenuates radiation-induced fibrosis in a murine model |
Q35035034 | Follistatin is induced by ionizing radiation and potentially predictive of radiosensitivity in radiation-induced fibrosis patient derived fibroblasts |
Q37411925 | Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans |
Q36040200 | Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients |
Q34935524 | From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration |
Q38839005 | Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis |
Q89564286 | Fructose-1,6-Bisphosphate Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice and Inhibits the Proliferation of Lung Fibroblasts |
Q33886281 | Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarring. |
Q37107125 | Functions of autophagy in normal and diseased liver |
Q53566281 | GGPPS deficiency aggravates CCl4-induced liver injury by inducing hepatocyte apoptosis. |
Q64949910 | Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice. |
Q48159180 | Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. |
Q37396937 | Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis |
Q26829291 | Gammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodents |
Q24634120 | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation |
Q90722857 | Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis |
Q82577081 | Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease |
Q37047953 | Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo |
Q34516594 | Gene expression analysis of the pleiotropic effects of TGF-β1 in an in vitro model of flexor tendon healing |
Q41779182 | Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro. |
Q38507233 | Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. |
Q37207519 | Genes regulated by caloric restriction have unique roles within transcriptional networks |
Q38210815 | Genetic determinants of pulmonary fibrosis: evolving concepts |
Q36722534 | Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice |
Q35110974 | Genetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infection |
Q30429015 | Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice |
Q35917468 | Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. |
Q90451156 | Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis |
Q36373332 | Genetic testing in diffuse parenchymal lung disease |
Q33912109 | Genome-wide RNA-Sequencing analysis identifies a distinct fibrosis gene signature in the conjunctiva after glaucoma surgery |
Q39875402 | Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis |
Q58800112 | Ghrelin Ameliorates Angiotensin II-Induced Myocardial Fibrosis by Upregulating Peroxisome Proliferator-Activated Receptor Gamma in Young Male Rats |
Q94560412 | Ginsenosides: potential therapeutic source for fibrosis-associated human diseases |
Q55966751 | Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation |
Q28533371 | Global gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosis |
Q35707164 | Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity |
Q40244126 | Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury |
Q36999185 | Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression |
Q34408266 | Graft versus host disease in the bone marrow, liver and thymus humanized mouse model |
Q64043403 | Growth rate and myofibroblast differentiation of desmoid fibroblast-like cells are modulated by TGF-β signaling |
Q35914655 | Gualou Xiebai decoction inhibits cardiac dysfunction and inflammation in cardiac fibrosis rats |
Q64084368 | HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases |
Q36588493 | HDAC inhibitors in experimental liver and kidney fibrosis |
Q47835828 | HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis |
Q50045865 | HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations. |
Q36991838 | Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model |
Q38046124 | Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis |
Q40858204 | Healing the scars of life-targeting redox imbalance in fibrotic disorders of the elderly |
Q35918416 | Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis. |
Q34978646 | Hematopoietic progenitor cell mobilization is mediated through beta-2 and beta-3 receptors after injury |
Q38010172 | Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? |
Q98771721 | Hepatic Stellate Cells and Hepatocarcinogenesis |
Q36167581 | Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan |
Q41707214 | Hepatic fibrogenesis and transforming growth factor/Smad signaling activation in rats chronically exposed to low doses of lead |
Q50061923 | Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol. |
Q36699261 | Hepatic regeneration and the epithelial to mesenchymal transition |
Q34361002 | Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants |
Q41360012 | Hepatocyte-specific ablation of PP2A catalytic subunit α attenuates liver fibrosis progression via TGF-β1/Smad signaling. |
Q43045645 | Hepatotrophic factors reduce hepatic fibrosis in rats |
Q36502066 | Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway |
Q34690834 | Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells |
Q42041903 | High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1. |
Q33916249 | High throughput determination of TGFβ1/SMAD3 targets in A549 lung epithelial cells |
Q47402576 | High-throughput approaches for screening and analysis of cell behaviors |
Q35632155 | Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro |
Q28571005 | Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins |
Q41774831 | Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation |
Q36907090 | Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts. |
Q48297020 | Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion. |
Q26852800 | Host responses in tissue repair and fibrosis |
Q37842633 | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? |
Q52536468 | Human Fibrotic Diseases: Current Challenges in Fibrosis Research. |
Q45501605 | Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. |
Q42465609 | Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression. |
Q41762985 | Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats |
Q28544929 | Hyaluronidase modulates inflammatory response and accelerates the cutaneous wound healing |
Q92246784 | Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice |
Q27011111 | Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis |
Q35640718 | Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease? |
Q28383532 | Hypoxia-Induced Epithelial-Mesenchymal Transition Is Involved in Bleomycin-Induced Lung Fibrosis |
Q37420926 | Hypoxia-induced collagen synthesis of human lung fibroblasts by activating the angiotensin system |
Q35022857 | Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells |
Q38038330 | ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context |
Q89542063 | IL-11 in cardiac and renal fibrosis: Late to the party but a central player |
Q46257233 | IL-11 is a crucial determinant of cardiovascular fibrosis. |
Q38010706 | IL-13 Signaling in Liver Fibrogenesis |
Q36102435 | IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. |
Q37396941 | IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis |
Q37474764 | IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. |
Q38990683 | ISSLS PRIZE IN BASIC SCIENCE 2017: Intervertebral disc/bone marrow cross-talk with Modic changes |
Q37424190 | Iatrogenic inflammatory fibrosis of hard palate in a 13-year-old female patient |
Q35942655 | Identification and characterization of an anti-fibrotic benzopyran compound isolated from mangrove-derived Streptomyces xiamenensis |
Q99371195 | Identification of differentially expressed long non-coding RNAs and mRNAs in orbital adipose/connective tissue of thyroid-associated ophthalmopathy |
Q34089734 | Identification of protein marker in vaginal wall tissues of women with stress urinary incontinence by protein chip array |
Q59136293 | Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney |
Q37304042 | Identification of two novel anti-fibrotic benzopyran compounds produced by engineered strains derived from Streptomyces xiamenensis M1-94P that originated from deep-sea sediments |
Q41856522 | Identifying common genes and networks in multi-organ fibrosis |
Q60956228 | Identifying the Growth Factors for Improving Neointestinal Regeneration in Rats through Transcriptome Analysis Using RNA-Seq Data |
Q27015533 | Immune Components of Liver Damage Associated with Connective Tissue Diseases |
Q55519564 | Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets. |
Q91666106 | Immune heterogeneity of head and tail pancreatic lymph nodes in non-obese diabetic mice |
Q58795413 | Immune mechanisms in the different phases of acute tubular necrosis |
Q30471805 | Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart |
Q42730468 | Immunohistochemical characterization of macrophages and myofibroblasts in α-Naphthylisothiocyanate (ANIT)--induced bile duct injury and subsequent fibrogenesis in rats |
Q37802002 | Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis |
Q46412441 | Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis |
Q38018539 | Immunological orchestration of liver fibrosis |
Q52658037 | Immunology Guides Skeletal Muscle Regeneration. |
Q90612947 | Immunomodulation for maxillofacial reconstructive surgery |
Q64935041 | Immunomodulation of liver injury by Ascaris suum extract in an experimental model of autoimmune hepatitis. |
Q38407555 | Immunopathogenesis of Myocarditis: The Interplay Between Cardiac Fibroblast Cells, Dendritic Cells, Macrophages and CD4+ T Cells |
Q38262108 | Immunopathogenesis of chronic hepatitis B. |
Q36070624 | Immunophenotypic alterations in resident immune cells and myocardial fibrosis in the aging rhesus macaque (Macaca mulatta) heart |
Q27339979 | Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels |
Q37403094 | In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha |
Q39003492 | In vitro methods of assessing ocular biocompatibility using THP-1-derived macrophages |
Q30313657 | In vitro study of the host responses to model biomaterials via a fibroblast/macrophage co-culture system. |
Q35131446 | In vivo metabolism study of xiamenmycin A in mouse plasma by UPLC-QTOF-MS and LC-MS/MS. |
Q37325619 | Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis |
Q33390722 | Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation |
Q35587144 | Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation |
Q36446246 | Increased peri-ductal collagen micro-organization may contribute to raised mammographic density. |
Q45348104 | Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation |
Q41625139 | Indoleamine 2, 3-dioxygenase (IDO) increases during renal fibrogenesis and its inhibition potentiates TGF-β 1-induced epithelial to mesenchymal transition. |
Q36015400 | Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response. |
Q36414300 | Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection |
Q83358567 | Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies |
Q46103260 | Induction of phenotype modifying cytokines by FERMT1 mutations. |
Q92691246 | Infiltrating CCR2+ monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1 |
Q38047815 | Inflammasomes in wound healing and fibrosis |
Q38107461 | Inflammation and liver tumorigenesis |
Q47305480 | Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. |
Q36352894 | Inflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren's Disease Fibroblasts. |
Q37631642 | Inflammatory Manifestations of Lymphedema |
Q34857355 | Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis. |
Q43877721 | Inflammatory response of intervertebral disc cells is reduced by fibrin sealant scaffold in vitro |
Q53580573 | Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis. |
Q33785553 | Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis |
Q29615715 | Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma |
Q39668344 | Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells |
Q38829813 | Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression |
Q38740549 | Inhibition of connective tissue growth factor attenuates paraquat-induced lung fibrosis in a human MRC-5 cell line |
Q43269848 | Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats |
Q37417291 | Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. |
Q35387975 | Inhibition of mechanical stress-induced hypertrophic scar inflammation by emodin |
Q35236478 | Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. |
Q37314369 | Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis |
Q51302199 | Inhibition of radiation-induced skin fibrosis with imatinib. |
Q46501803 | Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation |
Q35137520 | Inhibitory role of the KEAP1-NRF2 pathway in TGFβ1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling. |
Q38855505 | Injectable nanofibrous spongy microspheres for NR4A1 plasmid DNA transfection to reverse fibrotic degeneration and support disc regeneration. |
Q53402699 | Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases. |
Q35665474 | Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. |
Q39488300 | Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells |
Q77790315 | Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes |
Q42110868 | Integrative Systems Biology Investigation of Fabry Disease. |
Q47139621 | Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases. |
Q97421999 | Integrin alpha-5 silencing leads to myofibroblastic differentiation in IPF-derived human lung fibroblasts |
Q38219401 | Integrins and cadherins as therapeutic targets in fibrosis |
Q90666328 | Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical study |
Q47109594 | Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis |
Q38675553 | Interferon-γ Treatment of Human Laryngotracheal Stenosis-Derived Fibroblasts |
Q35197060 | Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. |
Q39855944 | Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling |
Q39609153 | Interleukin-13 is involved in the formation of liver fibrosis in Clonorchis sinensis-infected mice |
Q36379539 | Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype |
Q38753216 | Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy |
Q37572817 | Interleukin-6 signaling drives fibrosis in unresolved inflammation |
Q37433780 | Intestinal fibrosis in IBD--a dynamic, multifactorial process |
Q48174194 | Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease |
Q64893939 | Intratunical Injection of Human Adipose Tissue-Derived Stem Cells Restores Collagen III/I Ratio in a Rat Model of Chronic Peyronie's Disease. |
Q93112241 | Intratunical injection of autologous adipose stromal vascular fraction reduces collagen III expression in a rat model of chronic penile fibrosis |
Q33559677 | Investigating the role of P311 in the hypertrophic scar |
Q38992978 | Involvement of Nrf2-GSH signaling in TGFβ1-stimulated epithelial-to-mesenchymal transition changes in rat renal tubular cells |
Q37820315 | Involvement of bone-marrow-derived cells in kidney fibrosis |
Q99588205 | Is there a role for oxidative stress and mitochondrial dysfunction in age-associated bladder disorders? |
Q38756929 | Is there any role of epithelial to mesenchymal transition in the pathogenesis of contrast nephropathy? |
Q36101161 | Isoform-Specific Modulation of Inflammation Induced by Adenoviral Mediated Delivery of Platelet-Derived Growth Factors in the Adult Mouse Heart |
Q88947003 | Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition |
Q39945162 | IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice |
Q44062259 | JNK1/2 siRNA inhibits transforming-growth factor-beta1-induced connective tissue growth factor expression and fibrotic function in THSFs |
Q33756048 | KLF4 Plays an Essential Role in Corneal Epithelial Homeostasis by Promoting Epithelial Cell Fate and Suppressing Epithelial-Mesenchymal Transition |
Q64269669 | Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model |
Q38282776 | Klotho and renal fibrosis |
Q57718617 | La fibrose tubulo-interstitielle rénale |
Q54309806 | Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle. |
Q41894225 | Laser capture microdissection and multiplex-tandem PCR analysis of proximal tubular epithelial cell signaling in human kidney disease. |
Q48337942 | Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer |
Q49613258 | LepR+ cells dispute hegemony with Gli1+ cells in bone marrow fibrosis. |
Q34299086 | Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. |
Q40757564 | Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c |
Q26777122 | Leukocytes: The Double-Edged Sword in Fibrosis |
Q43777578 | Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury |
Q33747884 | Linking optics and mechanics in an in vivo model of airway fibrosis and epithelial injury |
Q93103164 | Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges |
Q41894153 | Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells |
Q57640526 | Lipopolysaccharide influences on the toxicity of oxidised multiwalled carbon nanotubes to murine splenocytesin vitro |
Q37109402 | Liver Injury and the Activation of the Hepatic Myofibroblasts |
Q30359290 | Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation |
Q38014650 | Liver fibrosis: a bidirectional model of fibrogenesis and resolution. |
Q34159097 | Liver fibrosis: an intravoxel incoherent motion (IVIM) study |
Q91942500 | Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation |
Q33438643 | Living-cell microarrays |
Q41879637 | Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis |
Q46405828 | Long non-coding RNA CHCHD4P4 promotes epithelial-mesenchymal transition and inhibits cell proliferation in calcium oxalate-induced kidney damage |
Q34117553 | Long-term alterations of cytokines and growth factors expression in irradiated tissues and relation with histological severity scoring |
Q58590513 | Long-term effectiveness of local BM-MSCs for skeletal muscle regeneration: a proof of concept obtained on a pig model of severe radiation burn |
Q38880396 | Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. |
Q58699037 | Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia |
Q35744613 | Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats |
Q50116500 | Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation. |
Q43272251 | Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice |
Q36749958 | Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis |
Q58803095 | Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p |
Q64084650 | Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing |
Q47130392 | Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation |
Q42696954 | Low oxygen tension positively influences cardiomyocyte progenitor cell function |
Q34470104 | Low-level laser therapy decreases renal interstitial fibrosis. |
Q27302984 | Lung Transcriptomics during Protective Ventilatory Support in Sepsis-Induced Acute Lung Injury |
Q58571239 | Lung fibroblasts express a miR-19a-19b-20a sub-cluster to suppress TGF-β-associated fibroblast activation in murine pulmonary fibrosis |
Q50142593 | Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis. |
Q35736010 | Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis. |
Q37857284 | Lysophosphatidic acid-1-receptor targeting agents for fibrosis. |
Q36680112 | M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo |
Q36437997 | MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response |
Q35889180 | MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation |
Q37811895 | MET signalling: principles and functions in development, organ regeneration and cancer |
Q60909538 | MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk |
Q99566895 | MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway |
Q33623144 | MLN4924 protects against bleomycin-induced pulmonary fibrosis by inhibiting the early inflammatory process |
Q35078509 | MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays |
Q54911489 | MMP-2 and MMP-9 activities and TIMP-1 and TIMP-2 expression in the prostatic tissue of two ethanol-preferring rat models. |
Q33858748 | MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score |
Q35687488 | MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells |
Q39125397 | Macrophage heterogeneity and renin-angiotensin system disorders. |
Q36369742 | Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results |
Q57801720 | Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland |
Q36610415 | Macrophage plasticity and the role of inflammation in skeletal muscle repair |
Q37990243 | Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine |
Q28084850 | Macrophage responses to implants: prospects for personalized medicine |
Q26774649 | Macrophages During the Fibrotic Process: M2 as Friend and Foe |
Q33793909 | Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration. |
Q33694114 | Macrophages are necessary for epimorphic regeneration in African spiny mice. |
Q34345718 | Macrophages are required for adult salamander limb regeneration |
Q34847925 | Macrophages are required for host survival in experimental urogenital schistosomiasis |
Q39331723 | Macrophages as Effectors of Acute and Chronic Allograft Injury |
Q40138821 | Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration. |
Q34518415 | Macrophages in Tissue Repair, Regeneration, and Fibrosis |
Q49609112 | Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance. |
Q34076279 | Macrophages: master regulators of inflammation and fibrosis |
Q39203728 | Magnetoelastic vibrational biomaterials for real-time monitoring and modulation of the host response |
Q26827231 | Management of fibrosis: the mesenchymal stromal cells breakthrough |
Q46362609 | Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction |
Q46028248 | Master regulators in primary skin fibroblast fate reprogramming in a human ex vivo model of chronic wounds. |
Q35947519 | Matrix Metalloproteinase Mediated Type I Collagen Degradation - An Independent Risk Factor for Mortality in Women. |
Q37589790 | Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles |
Q37150483 | Matrix control of scarring. |
Q35125630 | Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro |
Q55097343 | Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy. |
Q85789375 | Matrix remodeling response of human periodontal tissue cells toward fibrosis upon nicotine exposure |
Q37331561 | Mature adult dystrophic mouse muscle environment does not impede efficient engrafted satellite cell regeneration and self-renewal. |
Q33643242 | MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis |
Q51423153 | Measurement of liver T₁ and T₂ relaxation times in an experimental mouse model of liver fibrosis. |
Q42861912 | Mechanical offloading of incisional wounds is associated with transcriptional downregulation of inflammatory pathways in a large animal model |
Q54982400 | Mechanical signaling through the discoidin domain receptor 1 plays a central role in tissue fibrosis. |
Q89724754 | Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases |
Q29620307 | Mechanisms of fibrosis: therapeutic translation for fibrotic disease |
Q28079649 | Mechanisms of mesenchymal stem/stromal cell function |
Q34325432 | Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials |
Q33754181 | Mechanisms that mediate the development of fibrosis in patients with Crohn's disease |
Q26740308 | Mechanoregulation of Wound Healing and Skin Homeostasis |
Q38415445 | Mechanotransduction map: simulation model, molecular pathway, gene set. |
Q47318940 | Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis. |
Q34159587 | Mediators leading to fibrosis - how to measure and control them in tissue engineering. |
Q36191671 | Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation |
Q39036654 | Meprin β contributes to collagen deposition in lung fibrosis |
Q41855310 | Mesenchymal cell survival in airway and interstitial pulmonary fibrosis |
Q42007158 | Mesenchymal stem cell-mediated suppression of hypertrophic scarring is p53 dependent in a rabbit ear model |
Q37536886 | Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. |
Q47261430 | Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing. |
Q36752368 | Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension |
Q35577477 | Metchnikoff's policemen: macrophages in development, homeostasis and regeneration |
Q37452352 | Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages |
Q41073242 | MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy |
Q37745389 | MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. |
Q35251059 | MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar |
Q34252230 | MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma |
Q89043624 | MicroRNA-21a-5p promotes fibrosis in spinal fibroblasts after mechanical trauma |
Q36249425 | MicroRNAs as potential targets for progressive pulmonary fibrosis |
Q28067380 | MicroRNAs in fibrosis: opportunities and challenges |
Q54484920 | Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway. |
Q33827977 | Microarray analysis of differentially expressed genes in L929 mouse fibroblast cells exposed to leptin and hypoxia |
Q36122424 | Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. |
Q34040933 | Microarray profiling reveals the integrated stress response is activated by halofuginone in mammary epithelial cells |
Q38981232 | Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis |
Q38153432 | Microdeformation in wound healing |
Q38165635 | Microdialysis sampling techniques applied to studies of the foreign body reaction |
Q90414220 | Microenvironmental Alterations in Carbon Nanotube-Induced Lung Inflammation and Fibrosis |
Q36455290 | Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12 |
Q38119546 | Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte. |
Q36723373 | Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression |
Q27312202 | Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair. |
Q48176161 | Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine-Based Probe |
Q55497904 | Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis. |
Q59821288 | Molecular Probes for Imaging Fibrosis and Fibrogenesis |
Q38767584 | Molecular and Immunological Basis of Tubulo-Interstitial Injury in Lupus Nephritis: a Comprehensive Review. |
Q53337186 | Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis. |
Q52643365 | Molecular and histomorphological evaluation of female rats' urethral tissues after an innovative trauma model of prolonged vaginal distention: immediate, short-term and long-term effects. |
Q38121751 | Molecular basis of organ fibrosis: potential therapeutic approaches |
Q90348644 | Molecular determinants of mesenchymal cell activation in fibroproliferative diseases |
Q42230916 | Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis |
Q27692609 | Molecular mechanism and treatment of viral hepatitis-related liver fibrosis |
Q34142102 | Molecular mechanisms and treatment of radiation-induced lung fibrosis |
Q42185518 | Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases |
Q38032835 | Molecular serum markers of liver fibrosis. |
Q39369473 | Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis. |
Q34854719 | Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet |
Q38956732 | Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia |
Q42097897 | Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy |
Q36017652 | Morphological Retrospective Study of Peritoneal Biopsies from Patients with Encapsulating Peritoneal Sclerosis: Underestimated Role of Adipocytes as New Fibroblasts Lineage? |
Q36102198 | Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis. |
Q35641181 | Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition |
Q33576976 | Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy |
Q45266023 | Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-β/Smad signaling pathway |
Q50890635 | Murine Dermal Fibroblast Isolation by FACS. |
Q27011291 | Musculoskeletal regeneration and its implications for the treatment of tendinopathy |
Q97595650 | Mutations in COMP cause familial carpal tunnel syndrome |
Q34192783 | Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome |
Q31083702 | MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection |
Q38829400 | Mycophenolic acid reverses TGF beta-induced cell motility, collagen matrix contraction and cell morphology in vitro |
Q92155348 | Myeloid Differentiation Protein 2 Mediates Angiotensin II-Induced Liver Inflammation and Fibrosis in Mice |
Q37398699 | Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve. |
Q35174325 | Myocardial T1 mapping: techniques and potential applications |
Q45832826 | Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells |
Q38596113 | Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance. |
Q37641749 | Myocardial remodeling after infarction: the role of myofibroblasts |
Q35626103 | Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts. |
Q50522901 | Myofibroblast persistence and collagen type I accumulation in the human stenotic trachea. |
Q39063947 | Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective |
Q38294134 | Myofibroblast secretome and its auto-/paracrine signaling |
Q38064729 | Myofibroblast-mediated mechanisms of pathological remodelling of the heart |
Q42504323 | Myofibroblasts Are Evidence of Chronic Tissue Microtrauma at the Endometrial-Myometrial Junctional Zone in Uteri With Adenomyosis |
Q27969008 | Myofibroblasts and lung fibrosis induced by carbon nanotube exposure |
Q42503590 | Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis |
Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
Q89779500 | N-Acetyl-L-Cysteine Reduces Fibrosis and Improves Muscle Function After Acute Compartment Syndrome Injury |
Q34495678 | NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling |
Q33705075 | NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents |
Q47869398 | NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis |
Q42378502 | NOGO-B promotes EMT in lung fibrosis via MMP14 mediates free TGF-beta1 formation |
Q33649864 | NOX enzymes and pulmonary disease |
Q34645331 | Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress |
Q40487949 | Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection |
Q89630010 | Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment |
Q92276550 | Nephropathy in Hypertensive Animals Is Linked to M2 Macrophages and Increased Expression of the YM1/Chi3l3 Protein |
Q42486965 | Nestin expression is lost in ventricular fibroblasts during postnatal development of the rat heart and re-expressed in scar myofibroblasts |
Q64106971 | Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis |
Q34769969 | Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy |
Q42711532 | Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice |
Q35928300 | New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation |
Q52595252 | New and Emerging Treatments for Lymphedema. |
Q34720147 | New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis |
Q37709579 | New developments in the therapy of pulmonary fibrosis |
Q38388349 | New dog and new tricks: evolving roles for IL-33 in type 2 immunity |
Q27001340 | New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. lessons from the heart |
Q33560989 | New molecular medicine-based scar management strategies |
Q38246640 | New renal drug development to face chronic renal disease |
Q59796154 | Ninjurin1 Plays a Crucial Role in Pulmonary Fibrosis by Promoting Interaction between Macrophages and Alveolar Epithelial Cells |
Q90621396 | Nitrated fatty acids: from diet to disease |
Q91943325 | Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) in vivo |
Q91974913 | Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques |
Q28075809 | Nonsurgical treatment options in Peyronie's Disease: 2016 update |
Q37599394 | Not just angiotensinases: new roles for the angiotensin-converting enzymes |
Q39377055 | Novel Anti-fibrotic Therapies |
Q26738287 | Novel biomarkers of fibrosis in Crohn's disease |
Q28071302 | Novel concepts in radiation-induced cardiovascular disease. |
Q37934994 | Novel imaging techniques for diffuse myocardial fibrosis. |
Q35622533 | Novel insights into the function and dynamics of extracellular matrix in liver fibrosis |
Q36083434 | Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease |
Q33908275 | Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model |
Q33808050 | Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs |
Q33633102 | Obliterative airway remodelling in transplanted and non-transplanted lungs |
Q28067777 | Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer |
Q45870950 | Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis. |
Q30601730 | Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo |
Q43066618 | Omental adipose tissue fibrosis and insulin resistance in severe obesity. |
Q30485285 | Oncogenic Ras-transformed human fibroblasts exhibit differential changes in contraction and migration in 3D collagen matrices |
Q38763465 | Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation |
Q28743949 | Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos |
Q35607340 | Oral administration of marine collagen peptides prepared from chum salmon (Oncorhynchus keta) improves wound healing following cesarean section in rats |
Q37903909 | Oral cancers: supportive care issues |
Q37124381 | Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy |
Q46664712 | Oral tolerance attenuates changes in in vitro lung tissue mechanics and extracellular matrix remodeling induced by chronic allergic inflammation in guinea pigs. |
Q26863633 | Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts |
Q41592573 | Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis |
Q42469702 | Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders |
Q39337824 | Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation |
Q34839346 | Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis |
Q38839402 | Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection |
Q34598380 | Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell line |
Q42984072 | Oxidative Stress and Skin Fibrosis |
Q46860194 | Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β1 and TGF-β2-dependent pathway |
Q35666941 | Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain |
Q37861626 | PAI-1 in tissue fibrosis |
Q39212450 | PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice |
Q47102830 | PDGFR Signaling Mediates Hyperproliferation and Fibrotic Responses of Subsynovial Connective Tissue Cells in Idiopathic Carpal Tunnel Syndrome. |
Q41354166 | PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction |
Q37550306 | PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury. |
Q35507969 | Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling. |
Q43096273 | Paeoniflorin ameliorates schistosomiasis liver fibrosis through regulating IL-13 and its signalling molecules in mice |
Q43631328 | Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages |
Q34287169 | Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production |
Q37195998 | Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1 |
Q64072097 | Participation of NADPH Oxidase-Related Reactive Oxygen Species in Leptin-Promoted Pulmonary Inflammation: Regulation of cPLA2α and COX-2 Expression |
Q46038786 | Participation of functionally different macrophage populations and monocyte chemoattractant protein-1 in early stages of thioacetamide-induced rat hepatic injury. |
Q93075393 | Pathogenesis of fibrostenosing Crohn's disease |
Q38222245 | Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications |
Q35310907 | Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis |
Q34357219 | Pericytes at the intersection between tissue regeneration and pathology |
Q92421314 | Pericytes in Muscular Dystrophies |
Q92187715 | Pericytes: Problems and Promises for CNS Repair |
Q34201678 | Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle |
Q52600938 | Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis. |
Q26746998 | Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis |
Q33816291 | Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage |
Q92844811 | Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling |
Q53834988 | Petroleum coke exposure leads to altered secretome profiles in human lung models. |
Q42377201 | Pharmacological HIF-inhibition attenuates postoperative adhesion formation |
Q91792931 | Pharmacotherapy Agents in Lymphedema Treatment: A Systematic Review |
Q37944795 | Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. |
Q61950120 | Photoactivatable Hsp47: A Tool to Regulate Collagen Secretion and Assembly |
Q39251086 | Physical and Chemical Gradients in the Tumor Microenvironment Regulate Tumor Cell Invasion, Migration, and Metastasis |
Q49216178 | Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions. |
Q38146936 | Physiological changes to the swallowing mechanism following (chemo)radiotherapy for head and neck cancer: a systematic review |
Q46916695 | Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II. |
Q38256228 | Physiopathologic mechanisms involved in mare endometrosis |
Q90671891 | Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization |
Q37627860 | Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction |
Q41126008 | Pine bark extract (Pycnogenol®) suppresses cigarette smoke-induced fibrotic response via transforming growth factor-β1/Smad family member 2/3 signaling |
Q93111317 | Piperine ameliorates the severity of fibrosis via inhibition of TGF‑β/SMAD signaling in a mouse model of chronic pancreatitis |
Q92664052 | Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1 |
Q102141552 | Pirfenidone regulates LPS mediated activation of neutrophils |
Q36583294 | Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes. |
Q45071763 | Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma |
Q51337005 | Plasma rich in growth factors promotes dermal fibroblast proliferation, migration and biosynthetic activity. |
Q37344022 | Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling |
Q46148909 | Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors |
Q39953619 | Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-β levels and modulates the co-expression between collagen III and α-smooth muscle actin |
Q103826031 | Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model |
Q38444555 | Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction. |
Q50547237 | Possible involvement of inflammatory/reparative processes in the development of uterine fibroids. |
Q33628879 | Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice |
Q90319999 | Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy |
Q41834482 | Precision-Cut Kidney Slices as a Tool to Understand the Dynamics of Extracellular Matrix Remodeling in Renal Fibrosis. |
Q38842130 | Predicting pulmonary fibrosis in humans after exposure to multi-walled carbon nanotubes (MWCNTs). |
Q36125412 | Premature expression of a muscle fibrosis axis in chronic HIV infection |
Q30596295 | Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation. |
Q35025496 | Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion |
Q35072681 | Preventive effect of halofuginone on concanavalin A-induced liver fibrosis |
Q40902938 | Primary mouse lung fibroblasts help macrophages to tackle Mycobacterium tuberculosis more efficiently and differentiate into myofibroblasts up on bacterial stimulation |
Q89717434 | Principles of Cell Circuits for Tissue Repair and Fibrosis |
Q43068331 | Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis |
Q42126549 | Procollagen Lysyl Hydroxylase 2 Expression Is Regulated by an Alternative Downstream Transforming Growth Factor β-1 Activation Mechanism |
Q86672660 | Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts |
Q90639907 | Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis |
Q37364472 | Promising molecular targets and biomarkers for male BPH and LUTS |
Q51835859 | Properties and Immune Function of Cardiac Fibroblasts. |
Q54257268 | Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation. |
Q38074716 | Prostanoids receptors signaling in different diseases/cancers progression |
Q41595234 | Prostatic fibrosis is associated with lower urinary tract symptoms |
Q34822091 | Prostatic fibrosis, lower urinary tract symptoms, and BPH |
Q38021378 | Proteases, cystic fibrosis and the epithelial sodium channel (ENaC). |
Q36678523 | Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling |
Q90598888 | Protective Role of Vitamin D in Renal Tubulopathies |
Q29620351 | Protective and pathogenic functions of macrophage subsets |
Q33594283 | Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy. |
Q51025454 | Protective effect of ulinastatin in patients with non-small cell lung cancer after radiation therapy: a randomized, placebo-controlled study. |
Q57458063 | Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice |
Q91893715 | Proteomic Analysis of Radiation-Induced Acute Liver Damage in a Rabbit Model |
Q36602953 | Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats |
Q32179716 | Puerarin attenuates renal fibrosis by reducing oxidative stress induced-epithelial cell apoptosis via MAPK signal pathways in vivo and in vitro |
Q42220886 | Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog |
Q35151307 | Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis |
Q34626008 | Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling. |
Q35571961 | Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 |
Q35966131 | Quantitative Three-Dimensional Imaging of Lipid, Protein, and Water Contents via X-Ray Phase-Contrast Tomography |
Q61172884 | Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease |
Q35029642 | Quantitative assessment of macrophage functions in repair and fibrosis |
Q87929596 | R-spondin2 activates hepatic stellate cells and promotes liver fibrosis |
Q42368982 | R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation |
Q57458560 | RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition. |
Q33510140 | Rac inhibition reverses the phenotype of fibrotic fibroblasts |
Q37777878 | Radiation Pulmonary Toxicity: From Mechanisms to Management |
Q34513806 | Radiation fibrosis of the vocal fold: from man to mouse. |
Q34149752 | Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis |
Q45058787 | Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. |
Q36750137 | Radiation-induced lung injury is mitigated by blockade of gastrin-releasing peptide. |
Q58696764 | Radiation-induced muscle fibrosis rat model: establishment and valuation |
Q38761174 | Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? |
Q95406381 | Radiotherapy toxicity |
Q33632810 | Radiotherapy-Induced Skin Reactions Induce Fibrosis Mediated by TGF-β1 Cytokine |
Q37264534 | Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure |
Q84020876 | Rapid quantification of myocardial fibrosis: a new macro-based automated analysis |
Q36335937 | Rapid tissue regeneration induced by intracellular ATP delivery-A preliminary mechanistic study. |
Q64259452 | Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis |
Q98471309 | Recapitulation of normal collagen architecture in embryonic wounded corneas |
Q39303904 | Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis |
Q26773161 | Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis |
Q50042214 | Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review. |
Q30414378 | Recent advances in molecular magnetic resonance imaging of liver fibrosis |
Q37204019 | Recent advances in the pathogenesis and diagnosis of liver fibrosis |
Q35528061 | Recruited exudative macrophages selectively produce CXCL10 after noninfectious lung injury |
Q50457515 | Recruitment and subsequent proliferation of bone marrow-derived cells in the postischemic kidney are important to the progression of fibrosis. |
Q38229320 | Recurrent HCV after liver transplantation-mechanisms, assessment and therapy |
Q38202115 | Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease |
Q42174211 | Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes |
Q92661408 | Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs |
Q85646545 | Regeneration of functional pronephric proximal tubules after partial nephrectomy in Xenopus laevis |
Q31113958 | Regeneration of soft tissues is promoted by MMP1 treatment after digit amputation in mice |
Q37767061 | Regulation and dysregulation of fibrosis in skeletal muscle |
Q42877527 | Regulation of Macrophage Polarization and Wound Healing |
Q37377434 | Regulation of pathogenesis and immunity in helminth infections |
Q37269243 | Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase |
Q91898704 | Regulatory T Cells in Respiratory Health and Diseases |
Q47412936 | Regulatory role of miR-18a to CCN2 by TGF-β1 signaling pathway in pulmonary injury induced by nano-SiO2. |
Q64271648 | Relationships Between Phenotype and Function of Blood CD4+ T-Cells and Ascending Thoracic Aortic Aneurysm: an Experimental Study |
Q50665394 | Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis. |
Q34398874 | Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. |
Q35033650 | Renal denervation prevents long-term sequelae of ischemic renal injury |
Q24657528 | Renal fibrosis |
Q37641420 | Renal ischemia/reperfusion-induced cardiac hypertrophy in mice: Cardiac morphological and morphometric characterization |
Q36574766 | Renal nerves drive interstitial fibrogenesis in obstructive nephropathy. |
Q38530466 | Renal risk associated with sodium phosphate medication: safe in healthy individuals, potentially dangerous in others |
Q37662113 | Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-γ maintains the epithelial phenotype and antagonizes renal fibrogenesis |
Q37368710 | Renal tubulointerstitial fibrosis: common but never simple. |
Q90576869 | Renin-angiotensin system in human coronavirus pathogenesis |
Q37499439 | Repair Potential of Matrix-Induced Bone Marrow Aspirate Concentrate and Matrix-Induced Autologous Chondrocyte Implantation for Talar Osteochondral Repair: Patterns of Some Catabolic, Inflammatory, and Pain Mediators |
Q40107399 | Repetitive Intradermal Bleomycin Injections Evokes T Helper Cell 2 Cytokine-driven Pulmonary Fibrosis |
Q64103031 | Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP |
Q24292825 | Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells |
Q28588339 | Response gene to complement 32 is essential for fibroblast activation in renal fibrosis |
Q90221459 | Response of Human Macrophages to Clinically Applied Wound Dressings Loaded With Silver |
Q41468014 | Response of fibroblasts to transforming growth factor-β1 on two-dimensional and in three-dimensional hyaluronan hydrogels |
Q44817032 | Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling |
Q37707648 | Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride |
Q26782048 | Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis |
Q37992246 | Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. |
Q23923914 | Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the Nrf2 pathway |
Q36066095 | Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion. |
Q36999832 | Reversal of myofibroblast differentiation by prostaglandin E(2). |
Q61807550 | Reversion of in vivo fibrogenesis by novel chromone scaffolds |
Q38218544 | Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. |
Q38956376 | Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis |
Q47133379 | Review: Metabolic Control of Immune System Activation in Rheumatic Diseases |
Q38044467 | Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features |
Q93157685 | Rhein alleviates renal interstitial fibrosis by inhibiting tubular cell apoptosis in rats |
Q36022483 | Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis |
Q38177241 | Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma |
Q26768585 | Role of Bone Marrow-Derived Fibroblasts in Renal Fibrosis |
Q54323819 | Role of MAPK signal pathways in differentiation process of M2 macrophages induced by high-ambient glucose and TGF-β1. |
Q36093326 | Role of MicroRNAs in Fibrosis |
Q37452120 | Role of PDGFs/PDGFRs signaling pathway in myocardial fibrosis of DOCA/salt hypertensive rats |
Q92097260 | Role of complement 3 in the pathogenesis of hypertension |
Q37224668 | Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis |
Q35168217 | Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders |
Q35838867 | Role of integrin-β3 protein in macrophage polarization and regeneration of injured muscle |
Q34360300 | Role of interleukin-13 in fibrosis, particularly systemic sclerosis |
Q38206408 | Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction |
Q40257840 | Role of matrix metalloproteinases in radiation-induced lung injury in alveolar epithelial cells of Bama minipigs |
Q36775830 | Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting |
Q38848481 | Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases |
Q37771768 | Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. |
Q39423496 | Role of nuclear factor kappa-B in phenytoin-induced gingival overgrowth |
Q24634546 | Role of pericytes in skeletal muscle regeneration and fat accumulation |
Q38096495 | Role of proteoglycans in the regulation of the skeletal muscle fibrotic response. |
Q38879747 | Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention. |
Q26747017 | Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension |
Q38083596 | Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease |
Q26999096 | Role of the lesion scar in the response to damage and repair of the central nervous system |
Q33742115 | Role of the microRNA-29 family in fibrotic skin diseases. |
Q36252926 | Role of γδ T Cells in Lung Inflammation |
Q30594252 | Roles of transforming growth factor-β1 and OB-cadherin in porcine cardiac valve myofibroblast differentiation. |
Q54331126 | Rosiglitazone attenuates activation of human Tenon's fibroblasts induced by transforming growth factor-β1. |
Q43198035 | S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats. |
Q36597265 | SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3β. |
Q38905039 | SMAD3 and SP1/SP3 Transcription Factors Collaborate to Regulate Connective Tissue Growth Factor Gene Expression in Myoblasts in Response to Transforming Growth Factor β. |
Q39251967 | SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner |
Q33702390 | Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy |
Q37856705 | Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition |
Q38187978 | Scarless wound healing |
Q38852162 | Scarless wound healing: finding the right cells and signals |
Q83155917 | Scarred by disease |
Q64098812 | Schistosome infection and its effect on pulmonary circulation |
Q37872589 | Scraping fibrosis: expressway to the core of fibrosis |
Q42723938 | Screening for antifibrotic compounds using high throughput system based on fluorescence polarization |
Q53132495 | Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidase. |
Q35749231 | Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization. |
Q33613035 | Selective measurement of α smooth muscle actin: why β-actin can not be used as a housekeeping gene when tissue fibrosis occurs. |
Q52837772 | Serum Decorin, Interleukin-1β, and Transforming Growth Factor-β Predict Hypertrophic Scarring Postburn. |
Q92617180 | Serum miR-21 correlates with the histological stage of chronic hepatitis B-associated liver fibrosis |
Q91235944 | Shared and distinct mechanisms of fibrosis |
Q34385825 | Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience |
Q37660726 | Significant contribution of TRPC6 channel-mediated Ca2+ influx to the pathogenesis of Crohn's disease fibrotic stenosis |
Q35359339 | Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells |
Q36066400 | Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy |
Q35063762 | Simultaneous transcriptional profiling of bacteria and their host cells |
Q31142754 | Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials |
Q38860573 | Skeletal muscle fibroblasts in health and disease |
Q37383098 | Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential |
Q34383439 | Skin wound healing and scarring: fetal wounds and regenerative restitution |
Q50000565 | Smad3-STAT3 crosstalk in pathophysiological contexts. |
Q55240535 | Soluble Mediators Produced by Pro-Resolving Macrophages Inhibit Angiogenesis. |
Q37596197 | Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats |
Q39134223 | Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells |
Q35138620 | Space radiation-associated lung injury in a murine model |
Q34921823 | Sphingolipids in pulmonary fibrosis |
Q33753317 | Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis? |
Q54119596 | Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2. |
Q37176189 | Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts |
Q36130909 | Sprouty is a negative regulator of transforming growth factor β-induced epithelial-to-mesenchymal transition and cataract. |
Q40159797 | Src family kinases in chronic kidney disease |
Q35033196 | Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo |
Q38046544 | Stem cell transplantation as a therapy for cardiac fibrosis. |
Q55401793 | Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models. |
Q38066022 | Steroid regulation of menstrual bleeding and endometrial repair |
Q38963936 | Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine |
Q27347907 | Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation |
Q35923079 | Stromal fibroblast-bone marrow-derived cell interactions: implications for myofibroblast development in the cornea |
Q34390606 | Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1. |
Q51542269 | Subset-specific alterations in frequencies and functional signatures of γδ T cells in systemic sclerosis patients. |
Q43174220 | Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine |
Q50280511 | Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling. |
Q37160141 | Superoxide overproduction and kidney fibrosis: a new animal model. |
Q39528046 | Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells |
Q36288420 | Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro |
Q28482696 | Suramin alleviates glomerular injury and inflammation in the remnant kidney |
Q35012404 | Suramin inhibits renal fibrosis in chronic kidney disease. |
Q85208809 | Suramin inhibits the development and progression of peritoneal fibrosis |
Q28536943 | Suramin: a potential therapy for diabetic nephropathy |
Q34373111 | Surgical approaches to create murine models of human wound healing |
Q35621434 | Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis |
Q36682162 | Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways |
Q55397863 | Swallowing Exercises: Will They Really Help Head and Neck Cancer Patients? |
Q23910477 | System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses |
Q28546811 | Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice |
Q104607826 | Systems biology predicts that fibrosis in tuberculous granulomas may arise through macrophage-to-myofibroblast transformation |
Q27002418 | T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage |
Q93024028 | T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis |
Q93049089 | T-cell positioning by chemokines in autoimmune skin diseases |
Q40725613 | TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease |
Q43599859 | TAK1 is required for dermal wound healing and homeostasis |
Q39878170 | TGF-beta1 induces human bronchial epithelial cell-to-mesenchymal transition in vitro |
Q91897242 | TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts |
Q37899212 | TGF-β signaling in fibrosis |
Q53821423 | TGF-β, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma. |
Q34772461 | TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair. |
Q38177343 | TGF-β1 as a therapeutic target for pulmonary fibrosis and COPD. |
Q42759660 | TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation |
Q28732072 | TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages |
Q90131166 | TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression |
Q92564621 | TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndrome |
Q42675950 | TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis |
Q37739786 | TLR3 modulates immunopathology during a Schistosoma mansoni egg-driven Th2 response in the lung |
Q34124196 | TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury |
Q35606977 | TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis |
Q41324289 | TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis |
Q52721826 | TNFSF14 (LIGHT) Exhibits Inflammatory Activities in Lung Fibroblasts Complementary to IL-13 and TGF-β. |
Q38935000 | TRPV4 ion channel is a novel regulator of dermal myofibroblast differentiation |
Q53270018 | Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway. |
Q92736402 | Targeted Therapies in Surgical Treatment of Lymphedema: A Systematic Review |
Q37008372 | Targeting NOX enzymes in pulmonary fibrosis |
Q43238854 | Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis |
Q89241989 | Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides |
Q99587532 | Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? |
Q37883929 | Targeting collagen expression in alcoholic liver disease |
Q37770947 | Targeting fibrosis in Duchenne muscular dystrophy |
Q39833975 | Targeting myofibroblasts in model systems of fibrosis by an artificial alpha-smooth muscle-actin promoter hybrid |
Q53544896 | Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats. |
Q45895068 | Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model |
Q38802207 | Telocytes in Chronic Inflammatory and Fibrotic Diseases |
Q38385217 | Tenascins in fibrotic disorders-from bench to bedside |
Q57170896 | Testing Natural Biomaterials in Animal Models |
Q37691158 | Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts |
Q34973340 | Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice |
Q37396933 | Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis |
Q36615191 | Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema |
Q36260811 | Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice |
Q27312584 | The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts |
Q38618679 | The Amniotic Membrane: Development and Potential Applications - A Review. |
Q35218947 | The Angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury |
Q36904042 | The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2- and Akt-dependent mechanism |
Q64101613 | The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma |
Q51584895 | The Combined Use of Losartan and Muscle-Derived Stem Cells Significantly Improves the Functional Recovery of Muscle in a Young Mouse Model of Contusion Injuries. |
Q92808191 | The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 Antagonists |
Q61798677 | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity |
Q91791424 | The Effect of Low-Power Laser Therapy on the TGF/β Signaling Pathway in Chronic Kidney Disease: A Review |
Q26776002 | The Elusive Antifibrotic Macrophage |
Q90546431 | The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism |
Q58719281 | The Importance of Biophysical and Biochemical Stimuli in Dynamic Skeletal Muscle Models |
Q36970134 | The Influence of Bone Marrow-Secreted IL-10 in a Mouse Model of Cerulein-Induced Pancreatic Fibrosis |
Q42101096 | The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis |
Q42080118 | The Jeremiah Metzger lecture. The origin of fibroblasts and the terminality of epithelial differentiation |
Q38173382 | The Juxtacanalicular Region of Ocular Trabecular Meshwork: A Tissue with a Unique Extracellular Matrix and Specialized Function |
Q64104639 | The MicroRNA miR-155 Is Essential in Fibrosis |
Q64095050 | The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review |
Q36652097 | The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis |
Q37784810 | The Orbital Fibroblast: A Key Player and Target for Therapy in Graves’ Ophthalmopathy |
Q91659694 | The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3 |
Q42694416 | The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis |
Q92188777 | The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy |
Q38129218 | The RESOLVE concept: approaching pathophysiology of fibroproliferative disease in aged individuals |
Q36407662 | The Relationship between Proliferative Scars and Endothelial Function in Surgically Revascularized Patients. |
Q37505068 | The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches |
Q92528775 | The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis |
Q38524619 | The Role of PPAR Gamma in Systemic Sclerosis |
Q38602815 | The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis |
Q89966619 | The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis |
Q52727884 | The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis. |
Q41975783 | The Role of the NLRP3 Inflammasome in Fibrosis |
Q47112999 | The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues |
Q49265933 | The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis. |
Q57538743 | The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review |
Q35989481 | The Use of Kosher Phenotyping for Mapping QTL Affecting Susceptibility to Bovine Respiratory Disease |
Q34670501 | The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. |
Q38131032 | The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus. |
Q33417978 | The association of lacrimal gland inflammation with alopecia areata |
Q42911392 | The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension |
Q47152481 | The chemokines CXCL12 and CXCL14 differentially regulate connective tissue markers during limb development. |
Q28386827 | The code of non-coding RNAs in lung fibrosis |
Q35067772 | The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling |
Q39001100 | The different roles of myosin IIA and myosin IIB in contraction of 3D collagen matrices by human fibroblasts |
Q92367121 | The double edge sword of fibrosis in cancer |
Q39633175 | The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response |
Q35018345 | The effect of p38MAPK on cyclic stretch in human facial hypertrophic scar fibroblast differentiation |
Q46157035 | The effect of sorafenib on hepatic stellate cells: implication of its effect on tumor microenvironment |
Q37354744 | The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. |
Q52589503 | The emerging role of fibrocytes in ocular disorders. |
Q26783047 | The emerging roles of β-arrestins in fibrotic diseases |
Q37409222 | The enigmatic cytokine oncostatin m and roles in disease |
Q47803510 | The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis |
Q35601285 | The extracellular matrix: an active or passive player in fibrosis? |
Q47205727 | The fibrotic tumor stroma |
Q36193804 | The genetic pleiotropy of musculoskeletal aging. |
Q36545542 | The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells |
Q35563973 | The immunological contribution to heterotopic ossification disorders |
Q37682484 | The immunology of fibrosis: innate and adaptive responses |
Q47652116 | The impact of SPARC on age-related cardiac dysfunction and fibrosis in Drosophila |
Q38321523 | The importance of extracellular matrix for cell function and in vivo likeness. |
Q50684000 | The inhibition effect and mechanism of SY0916 on pulmonary fibrosis. |
Q37424208 | The interaction of Thrombospondins with extracellular matrix proteins |
Q39421460 | The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal musc |
Q37427782 | The liaison between apoptotic cells and macrophages--the end programs the beginning. |
Q24633454 | The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing |
Q35780076 | The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing |
Q58115668 | The mechanisms and potential of stem cell therapy for penile fibrosis |
Q38050078 | The microbiome in wound repair and tissue fibrosis |
Q48364814 | The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells. |
Q37733670 | The myofibroblast matrix: implications for tissue repair and fibrosis. |
Q34106373 | The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction |
Q34994036 | The origin of fibroblasts and mechanism of cardiac fibrosis |
Q37839779 | The origin of interstitial myofibroblasts in chronic kidney disease |
Q40103784 | The orphan nuclear receptor RORα and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease |
Q37800756 | The pathogenesis of idiopathic pulmonary fibrosis. |
Q37040558 | The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells |
Q33354622 | The periprosthetic capsule and connective tissue diseases: a piece in the puzzle of autoimmune/autoinflammatory syndrome induced by adjuvants |
Q48100107 | The pro-fibrotic connective tissue growth factor (CTGF/CCN2) correlates with the number of necrotic-regenerative foci in dystrophic muscle |
Q34429947 | The promise of perfect adult tissue repair and regeneration in mammals: Learning from regenerative amphibians and fish. |
Q89187517 | The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis |
Q37807765 | The role of Hedgehog signaling in fibrogenic liver repair |
Q26796346 | The role of P2X7 receptors in tissue fibrosis: a brief review |
Q39062904 | The role of TGF-β1 during skeletal muscle regeneration. |
Q37955061 | The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example |
Q34061245 | The role of inflammatory and fibrogenic pathways in heart failure associated with aging. |
Q37376157 | The role of iron in the pathogenesis of endometriosis |
Q35046046 | The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. |
Q38024820 | The role of macrophages in healing the wounded lung |
Q50458666 | The role of macrophages in the development of human renal allograft fibrosis in the first year after transplantation. |
Q38246646 | The role of pericyte detachment in vascular rarefaction |
Q38543690 | The role of the acquired immune response in systemic sclerosis |
Q39117766 | The role of the extracellular matrix in primary myelofibrosis |
Q37356743 | The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach |
Q35654823 | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
Q36944484 | The significance of macrophage phenotype in cancer and biomaterials |
Q46911221 | The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis. |
Q21559629 | The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis |
Q37800217 | The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. |
Q38536374 | The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence |
Q48159638 | The two faces of enhanced stroma: Stroma acts as a tumor promoter and a steric obstacle. |
Q58783029 | The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis |
Q27014616 | The wound healing, chronic fibrosis, and cancer progression triad |
Q55289622 | Therapeutic Potential of Polyphenols in Cardiac Fibrosis. |
Q37573815 | Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials |
Q35534899 | Therapies from fucoidan; multifunctional marine polymers |
Q42502170 | Three distinct cell populations express extracellular matrix proteins and increase in number during skeletal muscle fibrosis |
Q57177120 | Three-dimensional bioprinting of stem-cell derived tissues for human regenerative medicine |
Q33499619 | Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation |
Q38660241 | Thy1 (CD90) Expression Is Elevated in Radiation-Induced Periprosthetic Capsular Contracture: Implication for Novel Therapeutics |
Q27003231 | Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging |
Q34772841 | Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection |
Q36494364 | Tissue remodeling in eosinophilic esophagitis |
Q50976924 | Tissue response to five commercially available peritoneal adhesion barriers-A systematic histological evaluation. |
Q41973622 | Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation. |
Q39226247 | Titanium dioxide nanoparticles induce matrix metalloprotease 1 in human pulmonary fibroblasts partly via an interleukin-1β-dependent mechanism. |
Q38561820 | Toll-Like Receptors and Tissue Remodeling: The Pro/Cons Recent Findings. |
Q42949359 | Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation |
Q37352820 | Toll-like receptors, wound healing, and carcinogenesis |
Q91792926 | Topical Approach to Delivering Targeted Therapies in Lymphedema Treatment: A Systematic Review |
Q42383547 | Toward an antifibrotic therapy for inflammatory bowel disease |
Q37709748 | Towards a safe and effective chlamydial vaccine: lessons from the eye |
Q34607259 | Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis |
Q38028888 | Traditional Chinese medicine and immune regulation |
Q94606276 | Transcriptome analysis identifies genes involved with the development of umbilical hernias in pigs |
Q64235758 | Transcriptome network analysis identifies protective role of the LXR/SREBP-1c axis in murine pulmonary fibrosis |
Q37642994 | Transcriptomics of post-stroke angiogenesis in the aged brain |
Q37428739 | Transforming growth factor beta as a therapeutic target in systemic sclerosis |
Q36072357 | Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model |
Q34408250 | Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways |
Q35527871 | Transglutaminase 2 and its role in pulmonary fibrosis. |
Q33652543 | Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA |
Q50198762 | Transplanting Human Skin Grafts onto Nude Mice to Model Skin Scars. |
Q54062963 | Traumatic muscle fibrosis: From pathway to prevention. |
Q37704966 | Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy |
Q35545347 | Treatment of chronic kidney diseases with histone deacetylase inhibitors |
Q54171744 | Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling. |
Q40926459 | Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells. |
Q37512338 | Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration |
Q35461630 | Trps1 regulates biliary epithelial-mesenchymal transition and has roles during biliary fibrosis in liver grafts: a preliminary study |
Q90355553 | Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis |
Q39325865 | Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis |
Q37018721 | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway |
Q37950602 | Tumor promotion via injury- and death-induced inflammation |
Q39268764 | Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. |
Q38542046 | Two sides of one coin: massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure |
Q55241957 | Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis. |
Q37439840 | Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle |
Q40293690 | Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model. |
Q41537028 | Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease |
Q50071959 | Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy. |
Q33631115 | Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis |
Q39143837 | Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction |
Q36930956 | Understanding the host response to cell-laden poly(ethylene glycol)-based hydrogels |
Q39699112 | Understanding the process of fibrosis in Duchenne muscular dystrophy. |
Q36673270 | Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target |
Q47131777 | Up-regulation of Interleukin-21 Contributes to Liver Pathology of Schistosomiasis by Driving GC Immune Responses and Activating HSCs in Mice |
Q38183300 | Update on etiopathogenesis of systemic sclerosis |
Q37777155 | Update on the pathophysiology of liver fibrosis |
Q37196021 | Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis |
Q81786197 | Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease |
Q37711116 | Urinary collagen degradation products as early markers of progressive renal fibrosis |
Q38837268 | Use of Xenopus Frogs to Study Renal Development/Repair |
Q38850046 | Use of single chain antibody derivatives for targeted drug delivery |
Q58806294 | VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury |
Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
Q37110345 | Vascular endothelium as a novel source of stem cells for bioengineering |
Q36835180 | Vascular-targeted therapies for Duchenne muscular dystrophy |
Q38149507 | Vein graft failure |
Q33820772 | Ventral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration |
Q26770160 | View from the heart: cardiac fibroblasts in development, scarring and regeneration |
Q36117933 | Vitamin D Attenuates Kidney Fibrosis via Reducing Fibroblast Expansion, Inflammation, and Epithelial Cell Apoptosis |
Q24642477 | WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death |
Q42593075 | Welcome to fibrogenesis & tissue repair |
Q36579608 | Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis |
Q56981752 | Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease |
Q28482173 | Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo |
Q38135328 | Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis |
Q35044387 | Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1. |
Q37591028 | Wound repair at a glance |
Q38940635 | XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4. |
Q92132055 | Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Coloca |
Q53624421 | [The epithelial-mesenchymal transition and fibrosis of the renal transplant]. |
Q101476490 | c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis |
Q40803465 | iNOS Activity Modulates Inflammation, Angiogenesis, and Tissue Fibrosis in Polyether-Polyurethane Synthetic Implants |
Q41955066 | iTRAQ-based proteomic profiling reveals different protein expression between normal skin and hypertrophic scar tissue |
Q36108865 | miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. |
Q35154821 | miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis |
Q38795098 | miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. |
Q35219800 | miR-29 is a major regulator of genes associated with pulmonary fibrosis. |
Q36615791 | miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2 |
Q43434222 | microRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model |
Q60045578 | microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway |
Q61443226 | sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19/miR-675/let-7 and miR-21 pathways |
Q37629834 | uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin |
Q47213785 | α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis. |
Q37634132 | β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis |
Search more.